MedImpact Healthcare Systems, Inc.’s Post

#GLP1s have become the #drugclass of choice in the weight loss category. In this MedTalks Minute, hear our VP of #Clinical Services, Mary Rappl Bellanti, discuss the current landscape of these popular drugs. Stay tuned for Part Two to hear what #payers need to know! #wearemedimpact #atruepartner #weightmanagement #drugtrends #medtalksminute

To view or add a comment, sign in

Explore topics